| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |